Effect of exercise training on calpain systems in lean and obese Zucker rats

International Journal of Biological Sciences

Volumn 4, Issue 5, 2008, Pages 300-308

  Hsieh, Yao Yuan ^a,b   Chang, Chi Chen ^a,b   Hsu, Kung Hao ^c   Tsai, Fuu Jen ^b,d   Chen, Chih Ping ^e   Tsai, Horng Der ^f  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b China Medical University

^c TUNGHAI UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Calpain; Diabetes; Exercise; Obesity; Skeletal muscle

Indexed keywords

BETA ACTIN; CALPAIN 1; CALPAIN 10; CALPAIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TREADMILL EXERCISE; WESTERN BLOTTING;

RATTUS;

EID: 51849118739     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4.300     Document Type: Article

References (38)

1. Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol. 1997;273(6 Pt 1):E1039-51.
2. Crettaz M., Prentki M., Zaninetti D., and Jeanrenaud B. Insulin resistance in soleus muscle from obese Zucker rats. Biochem J 1983;86: 525-534.
3. Brozinick JT Jr, Etgen GJ Jr, Yaspelkis BB 3rd, Kang HY, Ivy JL. Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. Am J Physiol. 1993;265: E419-27.
4. Ayre KJ, Phinney SD, Tang AB, Stern JS. Exercise training reduces skeletal muscle membrane arachidonate in the obese (fa/fa) Zucker rat. J Appl Physiol. 1998;85: 1898-902.
5. Lee SD, Nakano H, Farkas GA. Adenosinergic modulation of ventilation in obese zucker rats. Obes Res. 2005;13: 545-55.
6. King PA, Horton ED, Hirshman MF, Horton ES. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest. 1992;90: 1568-75.
7. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26: 163-75.
8. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, et al. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes. 2002;51: 3561-7.
9. Dayton WR, Reville WJ, Goll DE, Stromer MH. A Ca2+activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme. Biochemistry. 1976;15: 2159-67.
10. Kang ES, Kim HJ, Nam M, Nam CM, Ahn CW, Cha BS, Lee HC. A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes. J Hum Genet. 2006; 51(7):629-33
11. Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y, Ohno S. Regulation of activity of calcium activated neutral protease. Adv Enzyme Regul. 1988;27: 153-69.
12. Sugita H, Ishiura S, Suzuki K, Imahori K. Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils. Muscle Nerve. 1980;3: 335-9.
13. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest. 2000;106: R69-73.
14. Goll DE, Thompson VF, Taylor RG, Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays. 1992;14: 549-56.
15. Yoshimura N, Murachi T, Heath R, Kay J, Jasani B, Newman GR. Immunogold electron-microscopic localisation of calpain I in skeletal muscle of rats. Cell Tissue Res. 1986;244: 265-70.
16. Hong DH, Huan J, Ou BR, Yeh JY, Saido TC, Cheeke PR, Forsberg NE. Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim Biophys Acta. 1995;1267: 45-54.
17. Ilian MA, Forsberg NE. Gene expression of calpains and their specific endogenous inhibitor, calpastatin, in skeletal muscle of fed and fasted rabbits. Biochem J. 1992;287 ( Pt 1):163-71.
18. Derbel S, Doumaguet C, Hubert D, Mosnier-Pudar H, Grabar S, Chelly J, Bienvenu T. Calpain 10 and development of diabetes mellitus in cystic fibrosis. J Cyst Fibros. 2006;5: 47-51.
19. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Manaka H, Kato T. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract. 2002;56: 147-52.
20. Herasse M, Ono Y, Fougerousse F, Kimura E, Stockholm D, Beley C, Montarras D, Pinset C, Sorimachi H, Suzuki K, Beckmann JS, Richard I. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol. 1999;19: 4047-55.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248-54.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227: 680-5.
23. Guroff G. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem. 1964;239: 149-155
24. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J. 1997; 328 (Pt. 3):721-732
25. Suzuki K, Sorimachi H, Yoshizawa T, Kinbara K, Ishiura S. Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe Seyler. 1995;376: 523-9.
26. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med. 2001;7: 355-62.
27. Wang KK, Yuen PW. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol Sci. 1994;15: 412-9.
28. Kent MP, Spencer MJ, Koohmaraie M. Postmortem proteolysis is reduced in transgenic mice overexpressing calpastatin. J Anim Sci Mar. 2004;82: 794-801.
29. Suzuki K, Ohno S. Calcium activated neutral protease - structure-function relationship and functional implications. Cell Struct Funct. 1990;15: 1-6.
30. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, et al. Calpains play a role in insulin secretion and action. Diabetes. 2001;50: 2013-20.
31. Otani K, Han DH, Ford EL, Garcia-Roves PM, Ye H, Horikawa Y, Bell GI, Holloszy JO, Polonsky KS. Calpain system regulates muscle mass and glucose transporter GLUT4 turnover. J Biol Chem. 2004;279: 20915-20.
32. Stalker TJ, Gong Y, Scalia R. The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes. 2005;54: 1132-40.
33. Takai Y, Yamamoto M, Inoue M, Kishimoto A, Nishizuka Y. A proenzyme of cyclic nucleotide-independent protein kinase and its activation by calcium-dependent neutral protease from rat liver. Biochem Biophys Res Commun. 1977;77: 542-50.
34. Turner MD, Cassell PG, Hitman GA. Calpain-10: from genome search to function. Diabetes Metab Res Rev. 2005;21: 505-14.
35. Branca D. Calpain-related diseases. Biochem Biophys Res Commun. 2004;322: 1098-104.
36. Carlsson E, Poulsen P, Storgaard H, Almgren P, Ling C, Jensen CB, Madsbad S, Groop L, Vaag A, Ridderstrale M. Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. Diabetes. 2005;54: 3015-20.
37. Xiang L, Naik J, Hester RL. Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2005;288: R987-91.
38. Etgen GJ Jr, Jensen J, Wilson CM, Hunt DG, Cushman SW, Ivy JL. Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface. Am J Physiol. 1997;272: E864-9.